Dr. Skoulidis and Terri Conneran Discuss Treatment Strategy for Lung, Colon, and Pancreatic Cancers Published -- Download video MP4 360p Recommendations 28:35 Terri's Story of Diagnosis and Treatment of Stage 3A Lung Cancer (1/3) 31:51 Lung Cancer Breakout: Breakthrough treatments for longer life 1:01:44 Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras 53:09 Dr. Salman Punekar, Pan-Ras Trials at the 2024 Hope Filled Summit 1:34:16 FDA Patient Listening Session "Drug Development in Molecular Subsets of Non-Small Cell Lung Cancer" 1:03:39 Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers 39:55 If You Get COVID 19: Optimize Immune System (Vitamin D, Monoclonal Antibodies, NAC, Quercetin etc.) 1:02:49 PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD 15:38 Dr. Channing Der, What is KRAS at the 2024 Hope Filled Summit 38:01 Melanoma Immunotherapy with Dr. Jedd Wolchok 56:37 Lung cancer molecular testing 1:12:11 Diffuse Large B Cell Lymphoma From Diagnosis to Treatment 1:10:23 PVCs: The Good, The Bad and The Ugly (Fermin C. Garcia, MD) February 7, 2019 26:22 Cancer Immunotherapy 101 with Dr. E. John Wherry 32:12 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC): Front Line Therapy 26:36 T Cell Activation and Control 1:02:36 Cancer Revealed: How the Immune System Sees and Destroys Tumors, with Jeffrey Weber Similar videos 1:25:49 Dr Mark Awad, M.D, Ph.D.on KRAS-Driven Cancers and Strategies to Overcome Resistance 58:46 Dr. David Hong on KRAS G12C Inhibitors and the Path Ahead - A Conversation with Terri Conneran 5:15:21 KRAS Kickers Connect, October 1, 2022 (entire event) 01:14 @KRASKickers Cancer Patients Need to Know 2:02:33 Kicking Cancer's Cancer Expert Series: A Conversation with Dr. Marcelo Negrao and Terri Conneran 05:53 Overcoming Barriers to Clinical Trials 00:44 Giuseppe Giaccone, PhD, MD, comments on the incidence of HLA-A2 positive (NSCLC) 08:15 This Research Could Change Cancer Treatment Forever 06:04 ARROW: clinical activity of pralsetinib in RET-fusion positive solid tumors 04:30 Drugging the Elusive KRAS 1:29:43 November 17, 2021 | Smilow Shares: Lung Cancer Awareness Month 00:49 The importance of METex14 testing in NSCLC 01:38 SOTORASIB: NEW DRUG DESTROYS LUNG CANCER 02:20 Adjuvant osimertinib in resected EGFRm NSCLC: the OS data from the ADAURA trial 07:21 Comparative Efficacy of Chemoimmunotherapy v Immunotherapy for 1st-Line Treatment of Advanced NSCLC 05:05 Is front-line anti-EGFR therapy essential in RAS-WT mCRC? More results